Evidence map›Paper›PMID 42801627›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Supramolecular Chiral Assemblies from Benzoselenadiazole-Alanine-Acylhydrazone Conjugates Enable Cardioprotection.

Jinkui Teng, Renjing Yang, Yu Du, Jingzhong Duan, Yiming Xu, Zhihua He, Guanghui Wang, Wenjing Tian, Aijie Liu, Haifeng Chen and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jinkui Teng *State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Renjing Yang *State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0003-3381-9170
Yu Du *State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Jingzhong DuanState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Yiming XuZhongshan Hospital Xiamen University, Xiamen, Fujian, China.
Zhihua HeZhongshan Hospital Xiamen University, Xiamen, Fujian, China.
Guanghui WangState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0009-0000-3722-8242
Wenjing TianState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Aijie LiuState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0002-0300-1872
Haifeng ChenState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Yun-Bao JiangDepartment of Chemistry, College of Chemistry and Chemical Engineering, The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, Xiamen University, Xiamen, China.
Xiaosheng YanState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0002-4207-9752

Funding

Fundamental Research Funds for the Central Universities 20720250104Fundamental Research Funds for the Central Universities 20720252003Jiangxi Provincial Natural Science Foundation 20252BAC240277National Science Foundation of China 22241503National Science Foundation of China 22674160National Science Foundation of China 92356308Natural Science Foundation of Fujian Province of China 2023J01038Xiamen City Department of Science and Technology 3502Z20251005Xiang An Biomedicine Laboratory 2025XAKJ0102009
6 · The paper itself

Abstract

Integrating structural order, permanent porosity, aqueous stability, and biological activity within a single supramolecular platform remains a central challenge in biomaterials science. Herein, we report a C

Indexed as

benzoselenadiazolecardioprotectionchalcogen bondingdoxorubicinsupramolecular chiral assembly

Identifiers

PMID42801627
PMCPMC13616315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.